CRIO in partnership with Pluto Health has announced the development of an integration between clinical care and clinical research. CRIO's Medical Records API delivers electronic medical records and other health histories, alongside clinical care coordination. The Pluto Health team then provides ongoing health maintenance support for potential participants. All this information is shared with patients, and with patient consent, can be shared with their clinicians and directly to principal investigators (PIs) at clinical research sites.
CRIO's partnership with Pluto Health leverages the recent trends towards patient centricity within clinical trials, focusing on addressing the patient journey in its entirey. It delivers a method to support patients' care pathways through clinical coordination, while streamlining PI workflow, and enabling patient control over their health information.
This approach goes beyond PIs access to EMR data. The approach reviews and reconciles health status before entry into the EDC, and offers care coordination tools to advance patient care alongside clinical research operations. Once review and reconciliation are completed, the source records are populated in the EDC and remote monitors can view the underlying sanitized medical records with principal investigator annotations, along with the source records. This level of transparency enhances sponsor oversight of quality and patient safety.
CRIO Announces Partnership with Pluto Health to Expand and Accelerate Clinical Trial Access. (2023, July 19). Cision PR Newsire.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Novel Agent Shows Superiority Over Placebo in Reducing Monthly Migraine Days
September 5th 2024Lu AG09222 shows promise as first-in-class medication that prevents neurogenic inflammation, vasodilation, and parasympathetic lacrimation, which are considered to be surrogate markers of migraine attacks.